Please Wait

Applying Filters...

Ciclopirox
KDMF
Table View

Molecular glue degraders: Lilly, AbbVie sign billion-dollar deals; BMS leads with three late-stage drugs

Data Compilation
#PharmaFlow

Pipeline Prospector Feb 2025: Bain buys Mitsubishi Tanabe for US$ 3.4 bn; Japan’s Ono gets FDA nod for rare joint tumor drug

Stock Recap
#PipelineProspector

Ciclopirox

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

10 API Suppliers, 6 USDMF, 5 CEP/COS, 1 KDMF, 5 NDC API, 5 Listed Suppliers, $ API Reference Price

FINISHED DOSAGE FORMULATIONS

93 FDF Dossiers, 32 FDA Orange Book, 54 Europe, 3 Canada, 4 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CREAM;TOPICAL - 0.77%, SUSPENSION;TOPICAL - 0.77%, GEL;TOPICAL - 0.77% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SOLUTION;TOPICAL - 8% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SHAMPOO;TOPICAL - 1%

RELATED EXCIPIENT COMPANIES

1 Seqens, 1 DKSH, 1 Faran Shimi Pharmaceutical, 5 Nanjing Well Pharmaceutical, 2 Actylis, 8 BASF, 2 Corel Pharma Chem, 1 Finar, 1 Kerry, 2 Lubrizol Life Science Health, 1 Pluviaendo, 1 Valens Pharmachem

EXCIPIENTS BY APPLICATIONS

13 Topical, 6 Parenteral, 5 Solubilizers, 3 Coating Systems & Additives, 3 Thickeners and Stabilizers, 3 Film Formers & Plasticizers, 3 Granulation, 2 Emulsifying Agents, 2 Controlled & Modified Release, 2 Lubricants & Glidants, 2 Taste Masking, 1 Direct Compression, 1 Surfactant & Foaming Agents

DIGITAL CONTENT

6 News #PharmaBuzz

6 News #PharmaBuzz

GLOBAL SALES INFORMATION

3 US Medicaid Prescriptions, 66 Regulatory FDF Prices

MARKET PLACE

8 APIs

8 APIs

PATENTS & EXCLUSIVITIES

1 Health Canada Patents

1 Health Canada Patents

REF. STANDARDS & IMPURITIES

4 EDQM, 3 USP, 6 Others

$ Xls download

Filters

Log in to access your PharmaMiles and download the data

Last Updated on PharmaCompass	Virtual Booth	Country	Registrant Name	Registration No.	Compound	Registration Date	Manufacturer	Manufacturer's Country	Manufacturer's Address
28/03/2025	Shanghai Pharma Group	China	Ace Biopharm Co., Ltd.	20190111-209-J-300	Ciclopirox	2019-01-11	Shanghai Pharma Group Changzhou Kony Pharmaceutical Co.,Ltd.	China	No. 35-1, Yixi Road, Daixi, Luoyang Town, Wujin District, Changzhou, Jiangsu 213105, China

Contact us
to update this info

Ciclopirox

Ciclopirox

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

10 API Suppliers

6 USDMF

5 CEP/COS

1 KDMF

5 NDC API

5 Listed Suppliers

$ API Reference Price

FINISHED DOSAGE FORMULATIONS

93 FDF Dossiers

32 FDA Orange Book

54 Europe

3 Canada

4 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CREAM;TOPICAL - 0.77%

SUSPENSION;TOPICAL - 0.77%

GEL;TOPICAL - 0.77% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

SOLUTION;TOPICAL - 8% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

SHAMPOO;TOPICAL - 1%

RELATED EXCIPIENT COMPANIES

1 Seqens

1 DKSH

1 Faran Shimi Pharmaceutical

5 Nanjing Well Pharmaceutical

2 Actylis

8 BASF

2 Corel Pharma Chem

1 Finar

1 Kerry

2 Lubrizol Life Science Health

1 Pluviaendo

1 Valens Pharmachem

EXCIPIENTS BY APPLICATIONS

13 Topical

6 Parenteral

5 Solubilizers

3 Coating Systems & Additives

3 Thickeners and Stabilizers

3 Film Formers & Plasticizers

3 Granulation

2 Emulsifying Agents

2 Controlled & Modified Release

2 Lubricants & Glidants

2 Taste Masking

1 Direct Compression

1 Surfactant & Foaming Agents

DIGITAL CONTENT

6 News #PharmaBuzz

GLOBAL SALES INFORMATION

3 US Medicaid Prescriptions

66 Regulatory FDF Prices

MARKET PLACE

8 APIs

PATENTS & EXCLUSIVITIES

1 Health Canada Patents

REF. STANDARDS & IMPURITIES

4 EDQM

3 USP

6 Others

Filters

GEL;TOPICAL - 0.77% Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

SOLUTION;TOPICAL - 8% Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons